Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant

Feasible Outcomes of T Cell–Replete Haploidentical Stem Cell Transplantation with Reduced-Intensity Conditioning in Patients with Myelodysplastic Syndrome

(2015) Seung-Hwan Shin et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

(2015) Yu Wang et al.   BLOOD

Haploidentical stem cell transplantation in patients aged 50 yr and older with leukemia: similar outcomes compared to younger adults

(2015) Yao Chen et al.   CLINICAL TRANSPLANTATION

Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy

(2015) H. Nakasone et al.   HAEMATOLOGICA

Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategy

(2015) H. Nakasone et al.   HAEMATOLOGICA

Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen–Matched Unrelated and Related Donors

(2014) Antonio Di Stasi et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Who is the best donor for a related HLA haplotype-mismatched transplant?

(2014) Y. Wang et al.   BLOOD

The hematopoietic cell transplantation-specific comorbidity index (HCT-CI) is an outcome predictor for partially matched related donor transplantation

(2013) Xiao-Dong Mo et al.   AMERICAN JOURNAL OF HEMATOLOGY

Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS)

(2013) W. Saber et al.   BLOOD

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

(2013) L. Malcovati et al.   BLOOD

How we treat lower-risk myelodysplastic syndromes

(2013) P. Fenaux et al.   BLOOD

Improved outcomes using G-CSF-mobilized blood and bone marrow grafts as the source of stem cells compared with G-PB after HLA-identical sibling transplantation in patients with acute leukemia

(2013) Xiao-su Zhao et al.   CLINICAL TRANSPLANTATION

Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation

(2013) Rainer Storb et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation

(2012) C.-H. Yan et al.   BLOOD

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

(2012) P. L. Greenberg et al.   BLOOD

Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia

(2012) Yu Wang et al.   CANCER

Incidence of invasive fungal disease after unmanipulated haploidentical stem cell transplantation was significantly higher than that after HLA-matched sibling transplantation

(2012) Y. Sun et al.   CLINICAL MICROBIOLOGY AND INFECTION

Haploidentical hematopoietic stem cell transplantation with unmanipulated granulocyte colony stimulating factor mobilized marrow and blood grafts

(2012) Ying-Jun Chang et al.   CURRENT OPINION IN HEMATOLOGY

Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings

(2012) N Kröger et al.   LEUKEMIA

Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

(2012) Claudio Anasetti et al.   NEW ENGLAND JOURNAL OF MEDICINE

Haploidentical Bone Marrow Transplantation Without T-Cell Depletion

(2012) Ying-Jun Chang et al.   SEMINARS IN ONCOLOGY

Reduced-intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic cell transplantation in acute leukemia and myelodysplastic syndrome

(2011) K.-H. Lee et al.   BLOOD

Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis

(2011) Y Wang et al.   BONE MARROW TRANSPLANTATION

Superior Graft-versus-Leukemia Effect Associated with Transplantation of Haploidentical Compared with HLA-Identical Sibling Donor Grafts for High-Risk Acute Leukemia: An Historic Comparison

(2010) Yu Wang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-mismatched hematopoietic SCT without in vitro T-cell depletion for myelodysplastic syndrome

(2010) Y Chen et al.   BONE MARROW TRANSPLANTATION

SAS macros for estimation of direct adjusted cumulative incidence curves under proportional subdistribution hazards models

(2010) Xu Zhang et al.   COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE

Risk stratification based on both disease status and extra-hematologic comorbidities in patients with myelodysplastic syndrome

(2010) M. G. Della Porta et al.   HAEMATOLOGICA

Results and factors influencing outcome after fully haploidentical hematopoietic stem cell transplantation in children with very high-risk acute lymphoblastic leukemia: impact of center size: an analysis on behalf of the Acute Leukemia and Pediatric Disease Working Parties of the European Blood and Marrow Transplant group

(2009) T. Klingebiel et al.   BLOOD

Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidity

(2009) J-H Lee et al.   BONE MARROW TRANSPLANTATION

Allogeneic stem cell transplantation for patients with refractory anaemia with matched related and unrelated donors: delay of the transplant is associated with inferior survival

(2009) Theo de Witte et al.   BRITISH JOURNAL OF HAEMATOLOGY